Skip to content

Low-Dose Caffeine and Taurine Effects on Performance

Synergistic Effects of Low-Dose Caffeine and Taurine on Anaerobic, Neuromuscular, and Cognitive Performance: A Double-Blind Randomized Placebo-Controlled Crossover Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07466654
Acronym
CATAP
Enrollment
32
Registered
2026-03-12
Start date
2025-10-15
Completion date
2025-11-15
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaerobic Performance Neuromuscular Performance Cognitive Performance

Keywords

caffeine, taurine, wingate, neuromuscular performance, cognitive performance

Brief summary

This study aims to investigate the effects of low-dose caffeine and taurine, administered separately and in combination, on anaerobic, neuromuscular, and cognitive performance. The study is designed as a randomized, double-blind, placebo-controlled crossover trial involving trained man participants. Each participant will complete experimental sessions under different supplementation conditions, including caffeine, taurine, their combination, and placebo. Performance outcomes will include anaerobic power, neuromuscular performance, and cognitive function assessments. The findings will help clarify whether the combined ingestion of caffeine and taurine produces synergistic performance effects compared with isolated supplementation.

Detailed description

Caffeine and taurine are commonly consumed ingredients in coffee and energy drinks and are frequently used as ergogenic aids to enhance physical and cognitive performance. Although both compounds have been widely investigated individually, evidence regarding their combined effects remains limited and inconsistent. Understanding whether caffeine and taurine produce synergistic or additive effects is important for clarifying their role in sports performance and supplementation strategies. The present study is designed as a randomized, double-blind, placebo-controlled crossover trial to examine the isolated and combined effects of low-dose caffeine and taurine on anaerobic, neuromuscular, and cognitive performance in trained individuals. Participants will complete multiple experimental sessions under different supplementation conditions, including caffeine, taurine, their combination, and placebo. During each session, participants will undergo standardized performance assessments to evaluate anaerobic power, neuromuscular performance, and cognitive function. The crossover design allows each participant to serve as their own control, minimizing inter-individual variability. The findings of this study may provide further insight into the potential synergistic effects of caffeine and taurine supplementation on performance outcomes.

Interventions

DIETARY_SUPPLEMENTCaffeine

Caffeine administered at a dose of 2 mg/kg body mass in capsule form, 60 minutes prior to performance testing.

DIETARY_SUPPLEMENTtaurine

Taurine administered at a dose of 10 mg/kg body mass in capsule form, 60 minutes prior to performance testing.

DIETARY_SUPPLEMENTCaffeine + Taurine

Combined supplementation of caffeine (2 mg/kg) and taurine (10 mg/kg) administered 60 minutes prior to testing.

DIETARY_SUPPLEMENTPlacebo

Placebo capsule containing maltodextrin (300 mg) administered 60 minutes prior to testing.

Sponsors

Ankara University
Lead SponsorOTHER
Burdur Mehmet Akif Ersoy University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Participants complete multiple experimental sessions under different supplementation conditions (caffeine, taurine, caffeine + taurine, and placebo) in a randomized crossover design. Each participant receives all interventions in separate sessions with appropriate washout periods.

Eligibility

Sex/Gender
MALE
Age
18 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Male participants aged 18 to 25 years * Regularly engaged in strength training at least three days per week for the previous 24 months * Apparently healthy with no self-reported cardiovascular, metabolic, neurological, or musculoskeletal disorders * Free from injuries affecting skeletal muscles, joints, or tendons during the previous two years

Exclusion criteria

* Use of medications or dietary supplements that may influence physical or cognitive performance * Known sensitivity or intolerance to caffeine or taurine * Consumption of caffeine or other stimulants within 24 hours prior to the testing sessions * Failure to comply with pre-testing instructions or study procedures

Design outcomes

Primary

MeasureTime frameDescription
Anaerobic Power60 minutes after supplementationAnaerobic power measured during the Wingate Anaerobic Test following supplementation conditions (caffeine, taurine, caffeine + taurine, and placebo).

Secondary

MeasureTime frameDescription
Neuromuscular Performance60 minutes after supplementationNeuromuscular performance assessed using handgrip strength measured with a hand dynamometer following supplementation.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORYakup Köse, MsC

Burdur Mehmet Akif Ersoy University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026